Skip to main content

Rajasthan

Crack GPAT — Prepare for GPAT Online 
  • SCREENING OF DIURETIC AGENTS-AN OVERVIEW

    About Authors:
    *Nilesh Sovasia, Prof.Sanjeev Thacker, Arshad Hala
    Seth G.L.Bihani S.D.College Of Technical Education,
    Institute Of Pharmaceutical Science & Drug Research,
    Sri Ganganagar,Rajasthan,India
    *nilesh.sovasia@yahoo.com

    ABSTRACT
    Diuretic agents are very useful for several critical conditions like hypertension, heart failure, renal failure, nephrotic syndrome, and cirrhosis.The various methods for screening of Diuretic agents provides useful tool to evaluate the safety and effectiveness of the drugs.It is also useful for determining the dose lavel of particular class of diuretic agents.

  • PROCEDURE TO OBTAIN PATENT IN INDIA

    About Authors:
    Arshad Hala*1, Prof. Rajesh Dholpuria1, Nilesh sovasia1
    1 Seth G. L. Bihani S. D. College Of Technical Education,
    Institute Of Pharmaceutical Sciences & Drug Research,
    Gaganpath, Sri Ganganagar, Rajasthan 335001
    *Arshad_hala@yahoo.com

    ABSTRACT:
    A patent is one of the forms of intellectual property. The object of patent law is to encourage scientific research, new technology and industrial progress. The grant of exclusive privilege to own, use or sell the method or product patented for a limited period, stimulates new inventions of commercial utility. The price of the grant of the monopoly is the disclosure of the invention at the patent office, which after the expiry of the period of monopoly, passes into public domain. An invention which must be new and useful. It must have novelty and utility. The patents are granted to encourage inventions and to secure that the inventions are worked in India on a commercial scale and to the fullest extent that is reasonable practicable without undue delay. So true inventor required to know how to get patent in india and other countries through his self or legal representative. Without patent no one use, sell, and research on invention.This review looks into procedure to obtain patent in india.

  • GOOD DISTRIBUTION PRACTICES-EXPECTATIONS FOR COMING DECADE

    About Authors:
    Middha Akanksha*, Kataria Sahil, Kukkar Vipin

    Seth G. L. Bihani S.D. College of Technical Education,
    Institute of Pharmaceutical Sciences and Drug Research,
    Sri Ganganagar, Rajasthan, INDIA
    *Akankshamddh@gmail.com

    Abstract
    Good Distribution Practice
     (GDP) deals with the guidelines for the proper distribution of medicinal products for human use. GDP is a quality warranty system, which includes requirements for purchase, receiving, storage and export of drugs intended for human consumption.

    GDP regulates the division and movement of pharmaceutical products from the premises of the manufacturer of medicinal products, or another central point, to the end user thereof, or to an intermediate point by means of various transport methods, via various storage and/or health establishments.

  • VALIDATION AND SECURITY MEASURES FOR PHARMACEUTICAL DATA PROCESSING

    About Authors:
    Krunal Parikh1*, Maheshkumar Kataria2
    1 M.Pharm, Quality Assurance,
    2
    Assistant professor, Department of pharmaceutics,
    Seth G.L. Bihani S.D. College of Technical Education,
    Institute of Pharmaceutical Sciences and Drug Research,
    Sri Ganganagar, Rajasthan, INDIA
    *Krunal_2922@yahoo.in

    ABSTRACT
    The Quality System regulation requires that “when computers or automated data processing systems are used as part of production or the quality system, the manufacturer shall validate computer software for its intended use according to an established protocol.” This has been a regulatory requirement for GMP since 1978. In addition to the above validation requirement, computer systems that implement part of a regulated manufacturer’s production processes or quality system (or that are used to create and maintain records required by any other FDA regulation) are subject to the Electronic Records, Electronic Signatures regulation. This regulation establishes additional security, data integrity, and validation requirements when records are created or maintained electronically. These additional Part 11 requirements should be carefully considered and included in system requirements and software requirements for any automated record keeping systems.

  • STEM CELLS AND PEPTIDES TO BRAIN VIA INTRASNASAL ROUTE

    About Authors:
    Ms.Pratibha Chohan*, Mr.Prashant Mutha
    B.Pharmacy, G. D. Memorial College of Pharmacy, Jodhpur.
    *pmuthabiotech@gmail.com

    ABSTRACT:
    Brain is tightly segregated from the circulating blood by a unique membranous barrier, the blood – brain barrier (BBB). Many pharmaceuticals cannot be efficiently delivered to, or sustained within the brain; hence they are ineffective in treating a plethora of cerebral diseases. Therefore, drug delivery methods that can provide drug delivery to brain or eventually preferential brain delivery (i.e. brain targeting) are of particular interest. One technique that holds promise for bypassing the BBB to deliver drugs to the brain and eliminating the surgical risk and the spillover effect of drug to normal tissue is the intranasal delivery.

    [adsense:336x280:8701650588]

  • Applications are invited for the positions of Hired contract based Researchers in G.B. Pant Institute of Himalayan Environment and Development

    G.B. Pant Institute of Himalayan Environment and Development (GBPIHED) was established in 1988-89, during the birth centenary year of Bharat Ratna Pt. Govind Ballabh Pant, as an autonomous Institute of the Ministry of Environment and Forests (MoEF), Govt.

  • ANALYSIS BY INSTRUMENTAL ANALYTICAL METHODS

    About Authors:
    Kapil Sharma*1, Subhash Gupta2
    1Yaresun Pharmaceutical Pvt. Ltd.,India.
    2Oasis test house ltd.jaipur-302006,rajasthan,india.
    *pharma_kapil@rediffmail.com

    INTRODUCTION
    Most of the manufacturing industries rely upon both qualitative and quantitative chemical analysis to ensure that the raw material used meet certain specification, and also to check quality of the final product. The unwanted compound may be harmful to manufacturing process or may appear as a harmful impurity in the final product.1

    A quantitative analysis is performed to establish the proportion of the essential component in the raw material. The final manufactured product is analyzed to ensure that its essential component is present within a predetermined range of composition and impurities do not exceed certain specified limit.

  • FORMULATION DESIGN, MANUFACTURE CRITERIA AND REQUIREMENT OF VARIOUS TYPES OF TABLET

    About Authors:
    1Sahu Deepak*, 2Ketawat Santosh
    1Ass.Professor, Geetanjali Institute of Pharmacy,
    2Lecturer, Geetanjali Institute of Pharmacy,
    Dabok, Udaipur [Rajasthan] – 313022
    *deepak.sahu.bhl@gmail.com

    Abstract
    Tablet is the most preferred oral dosage form, due to many advantages it offers to formulators as well as physicians and patients. However, the process of manufacturing tablets is complex. Hence, careful consideration has to be given to select right process, and right excipients to ultimately give a robust, high productivity and regulatory compliant product of good quality.

  • DIFFERENT METHODS OF ENHANCEMENT OF SOLUBILIZATION AND BIOAVAILABILITY OF POORLY SOLUBLE DRUGS: A RECENT REVIEW

    About Authors:
    Patel Chirag J*, Asija Rajesh, Asija Sangeeta
    Maharishi Arvind Institute of Pharmacy, Department of Pharmaceutics,
    Jaipur, Rajasthan.
    *chirag.bangalore@gmail.com

    ABSTRACT
    Solubility, the phenomenon of dissolution of solute in solvent to give a homogenous system, is one of the important parameters to achieve desired concentration of drug in systemic circulation for desired pharmacological response. Low aqueous solubility is the major problem encountered with formulation development of new chemical entities as well as for the generic development. The insufficient dissolution rate of the drug is the limiting factor in the oral bioavailability of poorly water soluble compounds. This review discusses BCS classification, carriers for solubility enhancement and different techniques for solubility enhancement.Various techniques are used for the enhancement of the solubility of poorly soluble drugs which include micronization, nanonization, sonocrystallization, supercritical fluid method, spray freezing into liquid and lyophilization, evaporative precipitation into aqueous solution, use of surfactant, use of co-solvent, hydrotropy method, use of salt forms, solvent deposition, solubilizing agents, modification of the crystal habit, co-crystallisation, complexation and drug dispersion in carriers.Selection of solubility improving method depends on drug property, site of absorption, and required dosage form characteristics.With the advent of combinatorial chemistry and a high throughput screening, the number of poorly water soluble compounds has increased solubility. A success of formulation depends on how efficiently it makes the drug available at the site of action.The purpose of this review article is to describe the techniques of solubilization for the attainment of effective absorption with improved bioavailability.

  • METHOD DEVELOPMENT AND ITS VALIDATION FOR ESTIMATION OF DEFLAZACORT IN TABLET DOSAGE FORM BY UV SPECTROPHOTOMETRY

    About Authors:
    Kapil Sharma*1, Subhash Gupta2, Priyanka Sharma1
    1Yaresun Pharmaceutical Pvt. Ltd.,India.
    2Oasis test house ltd.
    jaipur-302006,rajasthan,india.
    *pharma_kapil@rediffmail.com

    ABSTRACT
    This paper describe a simple, precise and economical spectrophotometric method for the quantitative determination of Deflazacort(DFCT) in tablet dosage form. Method is based on the estimation of DFCT in aqueous acetonitrileat 246 nm. Beer’s law was obeyed in the concentration range of 4-14 µg/ml. The accuracy of the method was assessed by recovery studies and was found to be 99.38±0.15 for DFCT. Results of the analysis were validated statistically so that it can be used for routine analysis of DFCT in tablet dosage form.

Subscribe to Rajasthan